For the year ending 2025-12-31, ANVS has $21,081,625 in assets. $4,230,375 in debts. $19,532,338 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 19,532,338 | |||
| Prepaid expenses and other current assets | 1,549,287 | |||
| Total assets | 21,081,625 | |||
| Accounts payable | 2,590,516 | |||
| Accrued expenses | 1,044,859 | |||
| Total current liabilities | 3,635,375 | |||
| Warrant liability | 595,000 | |||
| Total liabilities | 4,230,375 | |||
| Common stock - 0.0001 par value, 70,000,000 shares authorized, 27,199,139 and 14,141,521 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 2,719 | |||
| Additional paid-in capital | 180,552,190 | |||
| Accumulated deficit | -163,703,659 | |||
| Total stockholders' equity | 16,851,250 | |||
| Total liabilities and stockholders' equity | 21,081,625 | |||
Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc. (ANVS)